http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-018152-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9653ee35fe3474452dac8eab71f5c05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e884e581056f0990751f60e769cd9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287aae4eb8b777710a073b4340fc7564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57400905c6e473b7702549e6f4d7a074 |
| publicationDate | 2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-018152-B1 |
| titleOfInvention | CRYSTAL FORM OF METHYL DIHYDROCHLORIDE ((1S) -1 - (((2S) -2- (5- (4 '- (2 - ((2S) -1 - ((2S) -2 - ((METHOXYCARBONIL) AMINO) - 3-METHYLBUTANOIL) -2-PYRROLIDINYL) -1H-IMIDAZOL-5-IL) -4-BIPHENYLYL) -1H-IMIDAZOL-2-IL--1-PYRROLIDINYL) CARBONYL) -2-METHYLPROPYL) CARPHYLENYNYL) 2-CARBONYL-2-METHYLPROPYL-2-PYRROLIDINYL) -CARBONYL-2-METHYLPROPYLE-2-IL-1) |
| abstract | The description generally relates to the crystalline form of methyl dihydrochloride ((1S) -1 - (((2S) -2- (5- (4 '- (2 - ((2S) -1 - ((2S) -2 - (( methoxycarbonyl) amino) -3-methylbutanoyl) -2-pyrrolidinyl) -1H-imidazol-5-yl) -4-biphenylyl) -1H-imidazol-2-yl) -1-pyrrolidinyl) carbonyl) -2-methylpropyl) carbamate . The description generally also relates to a pharmaceutical composition comprising a given crystalline form, as well as methods for using the crystalline form in the treatment of hepatitis C and methods for producing such a crystalline form. |
| priorityDate | 2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.